"BSN medical covers the whole of the Canadian geography with our sales representatives, something we consider essential to be able to serve all patients and not…
In Conversation
"Looking ahead, Mylan observes an outstanding opportunity in the field of biosimilars, and this area is set to develop massively."
"As a company we invest in the manufacturing side of the business quite significantly, as well as in the product development and in the regulatory sphere."
"I think if you ask market players and the minister of health they would confirm that we are very active and we are trying to push…
"We are running a campaign called “Go to brand”, where we promote the Polish producer abroad in conferences and in general within Poland, compared to many…
"Price decreases are a good thing for Canadian citizens as it reduces their financial burden, but unfortunately, it has knock-on effects for pharmaceutical companies, especially those…
"The problem we face – reimbursement is based on local guidelines, that are not in line with international ones and it is quite difficult to convince…
"There are lots of ideas and we have also come with some proposals to the health authorities about how they should do it."
"The innovative power and capacity in Canada, its tremendous manufacturing potential and the highly skilled workforce needs to be put into a position to successfully grow…
"We are discovering the intellectual property for our customers, that makes us very strategic and important for them."
"e-Health is a system that will be used mainly in hospitals and despite the fact that B Braun provides the most modern equipment to these institutions,…
"Poland is now much more exposed to senior management and we are perceived as a priority market for Chiesi."
